Following arrest of CEO, KaloBios loses CFO, accountants, is delisted from Nasdaq.
Source: Martin Shkreli’s other pharma company is dramatically collapsing | Ars Technica
Following arrest of CEO, KaloBios loses CFO, accountants, is delisted from Nasdaq.
Source: Martin Shkreli’s other pharma company is dramatically collapsing | Ars Technica